{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T20:40:21Z","timestamp":1788813621148,"version":"build-2803163510"},"reference-count":71,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,7]],"date-time":"2021-10-07T00:00:00Z","timestamp":1633564800000},"content-version":"vor","delay-in-days":371,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["5P30CA013696"],"award-info":[{"award-number":["5P30CA013696"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U01 EY030580"],"award-info":[{"award-number":["U01 EY030580"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U54OD020351"],"award-info":[{"award-number":["U54OD020351"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R24EY028758"],"award-info":[{"award-number":["R24EY028758"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R24EY027285"],"award-info":[{"award-number":["R24EY027285"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["5P30EY019007"],"award-info":[{"award-number":["5P30EY019007"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01EY018213"],"award-info":[{"award-number":["R01EY018213"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01EY024698"],"award-info":[{"award-number":["R01EY024698"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01EY026682"],"award-info":[{"award-number":["R01EY026682"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R21AG050437"],"award-info":[{"award-number":["R21AG050437"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Schneeweiss Stem Cell Fund, New York State","award":["DHDOH01-C32590GG-3450000"],"award-info":[{"award-number":["DHDOH01-C32590GG-3450000"]}]},{"name":"Foundation Fighting Blindness New York Regional Research Center Grant","award":["PPA-1218-0751-COLU"],"award-info":[{"award-number":["PPA-1218-0751-COLU"]}]},{"name":"Nancy & Kobi Karp"},{"name":"Crowley Family Funds"},{"name":"he Rosenbaum Family Foundation"},{"DOI":"10.13039\/100007817","name":"Alcon Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007817","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012233","name":"Abeona Therapeutics","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100012233","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Gebroe Family Foundation"},{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Physician-Scientist Award"},{"name":"RPB, New York, NY, USA"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.ymthe.2020.08.012","type":"journal-article","created":{"date-parts":[[2020,8,25]],"date-time":"2020-08-25T16:17:31Z","timestamp":1598372251000},"page":"2139-2149","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":75,"title":["Therapy in Rhodopsin-Mediated Autosomal Dominant Retinitis Pigmentosa"],"prefix":"10.1016","volume":"28","author":[{"given":"Da","family":"Meng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara D.","family":"Ragi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9082-2427","authenticated-orcid":false,"given":"Stephen H.","family":"Tsang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2020.08.012_bib1","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/978-3-319-95046-4_25","article-title":"Retinitis pigmentosa (non-syndromic)","volume":"1085","author":"Tsang","year":"2018","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.ymthe.2020.08.012_bib2","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.preteyeres.2018.03.005","article-title":"Non-syndromic retinitis pigmentosa","volume":"66","author":"Verbakel","year":"2018","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.ymthe.2020.08.012_bib3","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1111\/aos.13141","article-title":"A review of the mechanisms of cone degeneration in retinitis pigmentosa","volume":"94","author":"Narayan","year":"2016","journal-title":"Acta Ophthalmol."},{"key":"10.1016\/j.ymthe.2020.08.012_bib4","first-page":"3971","article-title":"Precision metabolome reprogramming for imprecision therapeutics in retinitis pigmentosa","volume":"130","author":"Caruso","year":"2020","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.ymthe.2020.08.012_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1877-1173(09)88001-0","article-title":"Rhodopsin-mediated retinitis pigmentosa","volume":"88","author":"Malanson","year":"2009","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"key":"10.1016\/j.ymthe.2020.08.012_bib6","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1001\/archopht.1964.00970020106022","article-title":"Electrophysiological studies in early retinitis pigmentosa","volume":"72","author":"Gouras","year":"1964","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.ymthe.2020.08.012_bib7","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/BF00139576","article-title":"Retinitis pigmentosa and allied diseases: applications of electroretinographic testing","volume":"4","author":"Berson","year":"1981","journal-title":"Int. Ophthalmol."},{"key":"10.1016\/j.ymthe.2020.08.012_bib8","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1038\/343364a0","article-title":"A point mutation of the rhodopsin gene in one form of retinitis pigmentosa","volume":"343","author":"Dryja","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2020.08.012_bib9","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1056\/NEJM199011083231903","article-title":"Mutations within the rhodopsin gene in patients with autosomal dominant retinitis pigmentosa","volume":"323","author":"Dryja","year":"1990","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ymthe.2020.08.012_bib10","series-title":"Gene. RHO rhodopsin [Homo sapiens (human)]","year":"2020"},{"key":"10.1016\/j.ymthe.2020.08.012_bib11","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/S0002-9394(14)76726-1","article-title":"Retinal function and rhodopsin levels in autosomal dominant retinitis pigmentosa with rhodopsin mutations","volume":"112","author":"Jacobson","year":"1991","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.ymthe.2020.08.012_bib12","doi-asserted-by":"crossref","first-page":"7103","DOI":"10.1073\/pnas.95.12.7103","article-title":"Disease sequence from mutant rhodopsin allele to rod and cone photoreceptor degeneration in man","volume":"95","author":"Cideciyan","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2020.08.012_bib13","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1001\/archopht.1991.01080010094039","article-title":"Ocular findings in patients with autosomal dominant retinitis pigmentosa and a rhodopsin gene defect (Pro-23-His)","volume":"109","author":"Berson","year":"1991","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.ymthe.2020.08.012_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.preteyeres.2017.10.002","article-title":"The molecular and cellular basis of rhodopsin retinitis pigmentosa reveals potential strategies for therapy","volume":"62","author":"Athanasiou","year":"2018","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.ymthe.2020.08.012_bib15","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1126\/science.3485310","article-title":"Molecular genetics of inherited variation in human color vision","volume":"232","author":"Nathans","year":"1986","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2020.08.012_bib16","doi-asserted-by":"crossref","first-page":"4851","DOI":"10.1073\/pnas.81.15.4851","article-title":"Isolation and nucleotide sequence of the gene encoding human rhodopsin","volume":"81","author":"Nathans","year":"1984","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2020.08.012_bib17","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/nature05161","article-title":"Retinal repair by transplantation of photoreceptor precursors","volume":"444","author":"MacLaren","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2020.08.012_bib18","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1001\/archopht.1993.01090060049022","article-title":"A randomized trial of vitamin A and vitamin E supplementation for retinitis pigmentosa","volume":"111","author":"Berson","year":"1993","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.ymthe.2020.08.012_bib19","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1016\/j.ophtha.2016.06.049","article-title":"Five-year safety and performance results from the Argus II Retinal Prosthesis System clinical trial","volume":"123","author":"da Cruz","year":"2016","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ymthe.2020.08.012_bib20","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1097\/IIO.0000000000000256","article-title":"Retinitis pigmentosa: review of current treatment","volume":"59","author":"Wang","year":"2019","journal-title":"Int. Ophthalmol. Clin."},{"key":"10.1016\/j.ymthe.2020.08.012_bib21","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1016\/j.ophtha.2019.06.017","article-title":"Efficacy, safety, and durability of voretigene neparvovec-rzyl in RPE65 mutation-associated inherited retinal dystrophy: results of phase 1 and 3 trials","volume":"126","author":"Maguire","year":"2019","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ymthe.2020.08.012_bib22","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1089\/nat.2016.0656","article-title":"Molecular mechanisms of antisense oligonucleotides","volume":"27","author":"Crooke","year":"2017","journal-title":"Nucleic Acid Ther."},{"key":"10.1016\/j.ymthe.2020.08.012_bib23","doi-asserted-by":"crossref","first-page":"e323","DOI":"10.1212\/NXG.0000000000000323","article-title":"Antisense oligonucleotides: a primer","volume":"5","author":"Scoles","year":"2019","journal-title":"Neurol. Genet."},{"key":"10.1016\/j.ymthe.2020.08.012_bib24","first-page":"5719","article-title":"Allele specific knock-down of human P23H rhodopsin mRNA and prevention of retinal degeneration in humanized P23H rhodopsin knock-in mouse, following treatment with an intravitreal GAPmer antisense oligonucleotide (QR-1123)","volume":"60","author":"Biasutto","year":"2019","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ymthe.2020.08.012_bib25","doi-asserted-by":"crossref","first-page":"6362","DOI":"10.1167\/iovs.15-16400","article-title":"Allele-specific inhibition of rhodopsin with an antisense oligonucleotide slows photoreceptor cell degeneration","volume":"56","author":"Murray","year":"2015","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ymthe.2020.08.012_bib26","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/978-1-62703-119-6_12","article-title":"Short hairpin RNA-mediated gene silencing","volume":"942","author":"Lambeth","year":"2013","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.ymthe.2020.08.012_bib27","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/mt.2010.293","article-title":"Suppression and replacement gene therapy for autosomal dominant disease in a murine model of dominant retinitis pigmentosa","volume":"19","author":"Millington-Ward","year":"2011","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2020.08.012_bib28","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.ymthe.2005.03.028","article-title":"Toward a gene therapy for dominant disease: validation of an RNA interference-based mutation-independent approach","volume":"12","author":"Kiang","year":"2005","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2020.08.012_bib29","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1086\/519025","article-title":"RNA interference-mediated suppression and replacement of human rhodopsin in\u00a0vivo","volume":"81","author":"O\u2019Reilly","year":"2007","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ymthe.2020.08.012_bib30","doi-asserted-by":"crossref","first-page":"E8547","DOI":"10.1073\/pnas.1805055115","article-title":"Mutation-independent rhodopsin gene therapy by knockdown and replacement with a single AAV vector","volume":"115","author":"Cideciyan","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"4 Suppl 1","key":"10.1016\/j.ymthe.2020.08.012_bib31","first-page":"320","article-title":"AAV mediated RNA replacement as therapy in a mouse model of autosomal dominant retinitis pigmentosa","volume":"28","author":"Ahmed","year":"2020","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2020.08.012_bib32","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1126\/science.1232033","article-title":"RNA-guided human genome engineering via Cas9","volume":"339","author":"Mali","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2020.08.012_bib33","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1126\/science.1231143","article-title":"Multiplex genome engineering using CRISPR\/Cas systems","volume":"339","author":"Cong","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2020.08.012_bib34","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.cell.2020.03.023","article-title":"CRISPR-based therapeutic genome editing: strategies and in\u00a0vivo delivery by AAV vectors","volume":"181","author":"Wang","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2020.08.012_bib35","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/nature20565","article-title":"In\u00a0vivo genome editing via CRISPR\/Cas9 mediated homology-independent targeted integration","volume":"540","author":"Suzuki","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2020.08.012_bib36","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1038\/nature17946","article-title":"Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage","volume":"533","author":"Komor","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2020.08.012_bib37","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1038\/s41587-019-0032-3","article-title":"CRISPResso2 provides accurate and rapid genome editing sequence analysis","volume":"37","author":"Clement","year":"2019","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymthe.2020.08.012_bib38","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1016\/j.ophtha.2018.04.001","article-title":"Clustered regularly interspaced short palindromic repeats-based genome surgery for the treatment of autosomal dominant retinitis pigmentosa","volume":"125","author":"Tsai","year":"2018","journal-title":"Ophthalmology"},{"issue":"4 Suppl 1","key":"10.1016\/j.ymthe.2020.08.012_bib39","first-page":"108","article-title":"Dual AAV-based \u201cknock-out-and-replace\u201d of RHO as a therapeutic approach to treat RHO-associated autosomal dominant retinitis pigmentosa (RHO adRP)","volume":"28","author":"Diner","year":"2020","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2020.08.012_bib40","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/mt.2015.220","article-title":"In\u00a0vivo CRISPR\/Cas9 gene editing corrects retinal dystrophy in the S334ter-3 rat model of autosomal dominant retinitis pigmentosa","volume":"24","author":"Bakondi","year":"2016","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2020.08.012_bib41","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1089\/crispr.2017.0009","article-title":"Allele-specific CRISPR-Cas9 genome editing of the single-base P23H mutation for rhodopsin-associated dominant retinitis pigmentosa","volume":"1","author":"Li","year":"2018","journal-title":"CRISPR J."},{"issue":"4 Suppl 1","key":"10.1016\/j.ymthe.2020.08.012_bib42","first-page":"454","article-title":"Allele-specific CRISPR-Cas9 via dual AAV-mediated gene editing rescue retinal degeneration in a humanized RHO-P23H mouse model","volume":"28","author":"D\u2019Amico","year":"2020","journal-title":"Mol. Ther."},{"issue":"4 Suppl 1","key":"10.1016\/j.ymthe.2020.08.012_bib43","first-page":"286","article-title":"Specific knock-down of P347S dominant mutation in rhodopsin gene by CRISPR\/Cas9 system","volume":"28","author":"Patrizi","year":"2020","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2020.08.012_bib44","doi-asserted-by":"crossref","first-page":"3323","DOI":"10.1093\/nar\/24.17.3323","article-title":"Double strand break-induced recombination in Chlamydomonas reinhardtii chloroplasts","volume":"24","author":"D\u00fcrrenberger","year":"1996","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ymthe.2020.08.012_bib45","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/nbt.4182","article-title":"Meganuclease targeting of PCSK9 in macaque liver leads to stable reduction in serum cholesterol","volume":"36","author":"Wang","year":"2018","journal-title":"Nat. Biotechnol."},{"issue":"4 Suppl 1","key":"10.1016\/j.ymthe.2020.08.012_bib46","first-page":"1","article-title":"Therapeutic efficacy of ARCUS meganuclease gene editing\u2014arrest of rod degeneration and restoration of rod function in a transgenic pig model of autosomal dominant retinitis pigmentosa","volume":"28","author":"McCall","year":"2020","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2020.08.012_bib47","first-page":"941","article-title":"Autosomal dominant retinitis pigmentosa: absence of the rhodopsin proline\u2014histidine substitution (codon 23) in pedigrees from Europe","volume":"47","author":"Farrar","year":"1990","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ymthe.2020.08.012_bib48","doi-asserted-by":"crossref","first-page":"9370","DOI":"10.1073\/pnas.88.20.9370","article-title":"Mutation spectrum of the rhodopsin gene among patients with autosomal dominant retinitis pigmentosa","volume":"88","author":"Dryja","year":"1991","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2020.08.012_bib49","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1016\/j.ymthe.2020.03.015","article-title":"Variability in genome editing outcomes: challenges for research reproducibility and clinical safety","volume":"28","author":"Teboul","year":"2020","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2020.08.012_bib50","doi-asserted-by":"crossref","first-page":"E8","DOI":"10.1038\/s41586-018-0380-z","article-title":"Large deletions induced by Cas9 cleavage","volume":"560","author":"Adikusuma","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2020.08.012_bib51","doi-asserted-by":"crossref","first-page":"E10","DOI":"10.1038\/s41586-018-0381-y","article-title":"Ma et\u00a0al. reply","volume":"560","author":"Ma","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2020.08.012_bib52","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1038\/s41467-019-09006-2","article-title":"CRISPR-Cas9 genome editing induces megabase-scale chromosomal truncations","volume":"10","author":"Cullot","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2020.08.012_bib53","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/s41591-018-0326-x","article-title":"Identification of preexisting adaptive immunity to Cas9 proteins in humans","volume":"25","author":"Charlesworth","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2020.08.012_bib54","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1038\/s41588-020-0623-4","article-title":"Cas9 activates the p53 pathway and selects for p53-inactivating mutations","volume":"52","author":"Enache","year":"2020","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ymthe.2020.08.012_bib55","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1097\/IAE.0000000000002197","article-title":"CRISPR genome surgery in the retina in light of off-targeting","volume":"38","author":"Cho","year":"2018","journal-title":"Retina"},{"key":"10.1016\/j.ymthe.2020.08.012_bib56","series-title":"NIST Genome Editing Consortium","author":"Maragh","year":"2019"},{"key":"10.1016\/j.ymthe.2020.08.012_bib57","series-title":"Human gene therapy for retinal disorders: guidance for industry","year":"2020"},{"key":"10.1016\/j.ymthe.2020.08.012_bib58","doi-asserted-by":"crossref","first-page":"4903","DOI":"10.1073\/pnas.1712963115","article-title":"Nonviral gene editing via CRISPR\/Cas9 delivery by membrane-disruptive and endosomolytic helical polypeptide","volume":"115","author":"Wang","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2020.08.012_bib59","series-title":"Long term follow-up after administration of human gene therapy products: guidance for industry","year":"2020"},{"key":"10.1016\/j.ymthe.2020.08.012_bib60","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1038\/s41586-018-0500-9","article-title":"In\u00a0vivo CRISPR editing with no detectable genome-wide off-target mutations","volume":"561","author":"Akcakaya","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2020.08.012_bib61","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2019.100827","article-title":"Progress in treating inherited retinal diseases: Early subretinal gene therapy clinical trials and candidates for future initiatives","author":"Garafalo","year":"2020","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.ymthe.2020.08.012_bib62","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1080\/14712598.2020.1740676","article-title":"Voretigene neparvovec-rzyl for treatment of RPE65-mediated inherited retinal diseases: a model for ocular gene therapy development","volume":"20","author":"Ciulla","year":"2020","journal-title":"Expert Opin. Biol. Ther."},{"key":"10.1016\/j.ymthe.2020.08.012_bib63","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1016\/j.ophtha.2008.03.009","article-title":"Low luminance visual dysfunction as a predictor of subsequent visual acuity loss from geographic atrophy in age-related macular degeneration","volume":"115","author":"Sunness","year":"2008","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ymthe.2020.08.012_bib64","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/ceo.13022","article-title":"Novel mobility test to assess functional vision in patients with inherited retinal dystrophies","volume":"46","author":"Chung","year":"2018","journal-title":"Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.ymthe.2020.08.012_bib65","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1167\/tvst.8.4.16","article-title":"Performance of a defect-mapping microperimetry approach for characterizing progressive changes in deep scotomas","volume":"8","author":"Wu","year":"2019","journal-title":"Transl. Vis. Sci. Technol."},{"key":"10.1016\/j.ymthe.2020.08.012_bib66","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1167\/tvst.6.4.15","article-title":"Dark-adapted chromatic perimetry for measuring rod visual fields in patients with retinitis pigmentosa","volume":"6","author":"Bennett","year":"2017","journal-title":"Transl. Vis. Sci. Technol."},{"key":"10.1016\/j.ymthe.2020.08.012_bib67","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1080\/08820538.2020.1774624","article-title":"Biofeedback low vision rehabilitation with Retimax vision trainer in patients with advanced age-related macular degeneration: a pilot study","volume":"35","author":"Verdina","year":"2020","journal-title":"Semin. Ophthalmol."},{"key":"10.1016\/j.ymthe.2020.08.012_bib68","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1080\/21678707.2020.1735352","article-title":"Monitoring progression of retinitis pigmentosa: current recommendations and recent advances","volume":"8","author":"Menghini","year":"2020","journal-title":"Expert Opin. Orphan Drugs"},{"key":"10.1016\/j.ymthe.2020.08.012_bib69","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1167\/iovs.06-1131","article-title":"Increased sensitivity to light-induced damage in a mouse model of autosomal dominant retinal disease","volume":"48","author":"White","year":"2007","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ymthe.2020.08.012_bib70","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1167\/iovs.08-2936","article-title":"Thickness of receptor and post-receptor retinal layers in patients with retinitis pigmentosa measured with frequency-domain optical coherence tomography","volume":"50","author":"Hood","year":"2009","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ymthe.2020.08.012_bib71","series-title":"Artificial Street","year":"2020"}],"updated-by":[{"DOI":"10.1016\/j.ymthe.2022.06.007","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2022,7,6]],"date-time":"2022-07-06T00:00:00Z","timestamp":1657065600000}}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001620304226?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001620304226?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,13]],"date-time":"2022-07-13T04:59:09Z","timestamp":1657688349000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001620304226"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":71,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["S1525001620304226"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2020.08.012","relation":{"erratum":[{"id-type":"doi","id":"10.1016\/j.ymthe.2022.06.007","asserted-by":"object"}]},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapy in Rhodopsin-Mediated Autosomal Dominant Retinitis Pigmentosa","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2020.08.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020","name":"copyright","label":"Copyright"}]}}